Alvotech Ordinary Shares (ALVO) is a publicly traded Healthcare sector company. As of July 26, 2026, ALVO trades at $3.06 with a market cap of $1.03B and a P/E ratio of 0.00. ALVO moved -4.25% today. Year to date, ALVO is -40.35%; over the trailing twelve months it is -66.59%. Its 52-week range spans $2.94 to $13.70. Analyst consensus is sell with an average price target of $4.00. Rallies surfaces ALVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alvotech Insider Pledge of 88.9M Shares and 7M Depository Receipts: Celtic Lux Holdings S.à r.l. pledged 88,940,619 Alvotech shares and 7,007,321 depository receipts on June 26, 2026, per CSSF filings. The insider transaction by the entity formerly known as Alvogen Lux Holdings signals substantial stakeholder collateralization that could influence share supply and investor sentiment.
| Metric | Value |
|---|---|
| Price | $3.06 |
| Market Cap | $1.03B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.70 |
| 52-Week Low | $2.94 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover ALVO: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $4.00.